下载PDF
{"title":"Utilizing iVariantGuide for Variant Assessment of Next-Generation Sequencing","authors":"Sophia R. Chaudhry, Michael A. Tainsky","doi":"10.1002/cpbi.73","DOIUrl":null,"url":null,"abstract":"<p>Molecular genetic testing provides the capability for personalized prediction, diagnosis, and pharmacological treatments of disease and disorders. Variant assessment of next-generation sequencing (NGS) is a crucial component of genetic testing for clinicians to counsel patients on risk and management. The iVariantGuide application is a dynamic Web-based application made for the tertiary analysis of NGS. Along with variant assessment, iVariantGuide provides a unique interactive pathway impact analysis of genetic variants, as well as a unique Gene Ontology (GO) analysis. Here we provide a step-by-step guide on how to utilize iVariantGuide, employing a publicly available NGS dataset consisting of a cohort of germline DNAs from high-risk serous ovarian cancer (OVCA) patients. The application will be used to exhibit the ease in filtering down to a set of compelling novel variants and their impact on biological pathways and GO terms. © 2019 by John Wiley & Sons, Inc.</p>","PeriodicalId":10958,"journal":{"name":"Current protocols in bioinformatics","volume":"65 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpbi.73","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols in bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpbi.73","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 2
引用
批量引用
Abstract
Molecular genetic testing provides the capability for personalized prediction, diagnosis, and pharmacological treatments of disease and disorders. Variant assessment of next-generation sequencing (NGS) is a crucial component of genetic testing for clinicians to counsel patients on risk and management. The iVariantGuide application is a dynamic Web-based application made for the tertiary analysis of NGS. Along with variant assessment, iVariantGuide provides a unique interactive pathway impact analysis of genetic variants, as well as a unique Gene Ontology (GO) analysis. Here we provide a step-by-step guide on how to utilize iVariantGuide, employing a publicly available NGS dataset consisting of a cohort of germline DNAs from high-risk serous ovarian cancer (OVCA) patients. The application will be used to exhibit the ease in filtering down to a set of compelling novel variants and their impact on biological pathways and GO terms. © 2019 by John Wiley & Sons, Inc.
利用iVariantGuide进行下一代测序的变异评估
分子基因检测为疾病和失调的个性化预测、诊断和药理学治疗提供了能力。下一代测序(NGS)的变异评估是临床医生就风险和管理向患者提供咨询的基因检测的重要组成部分。iVariantGuide应用程序是一个动态的基于web的应用程序,用于NGS的三级分析。除了变体评估,iVariantGuide还提供了独特的遗传变异交互途径影响分析,以及独特的基因本体(GO)分析。在这里,我们提供了一个关于如何使用iVariantGuide的逐步指南,采用了一个公开可用的NGS数据集,包括来自高风险浆液性卵巢癌(OVCA)患者的种系dna队列。该应用程序将用于展示过滤到一组引人注目的新变体及其对生物途径和氧化石墨烯术语的影响的便利性。©2019 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。